Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6):e577.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mrózek K, Harper DP, Aplan PD. Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009;23(5):991-1010,v.

Article  PubMed  PubMed Central  Google Scholar 

Armstrong SA, Look AT. Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol. 2005;23(26):6306–15.

Article  CAS  PubMed  Google Scholar 

Mullighan CG. The molecular genetic makeup of acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2012;2012:389–96. https://doi.org/10.1182/asheducation-2012.1.389.

Article  PubMed  Google Scholar 

Luan C, Yang Z, Chen B. The functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapy. Onco Targets Ther. 2015;8:2903–14.

CAS  PubMed  PubMed Central  Google Scholar 

Grobbelaar C, Ford AM. The role of MicroRNA in paediatric acute lymphoblastic leukaemia: challenges for diagnosis and therapy. J Oncol. 2019;2019:8941471.

Article  PubMed  PubMed Central  Google Scholar 

Acunzo M, Romano G, Wernicke D, Croce CM. MicroRNA and cancer–a brief overview. Adv Biol Regul. 2015;57:1–9.

Article  CAS  PubMed  Google Scholar 

Turk A, Calin GA, Kunej T. MicroRNAs in leukemias: a clinically annotated compendium. Int J Mol Sci. 2022;23(7):3469.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yin Q, Wang X, McBride J, Fewell C, Flemington E. B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element. J Biol Chem. 2008;283(5):2654–62.

Article  CAS  PubMed  Google Scholar 

Thai T-H, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, et al. Regulation of the germinal center response by microRNA-155. Science. 2007;316(5824):604–8.

Article  CAS  PubMed  Google Scholar 

Fuziwara CS, Kimura ET. Insights into regulation of the miR-17-92 cluster of miRNAs in cancer. Front Med (Lausanne). 2015;2:64.

PubMed  Google Scholar 

Mogilyansky E, Rigoutsos I. The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ. 2013;20(12):1603–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Danielson LS, Reavie L, Coussens M, Davalos V, Castillo-Martin M, Guijarro MV, et al. Limited miR-17-92 overexpression drives hematologic malignancies. Leuk Res. 2015;39(3):335–41.

Article  CAS  PubMed  Google Scholar 

Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, Ohyashiki K, et al. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS One. 2009;4(5):e5532.

Article  PubMed  PubMed Central  Google Scholar 

Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2012;119(1):296–307.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goker H, Haznedaroglu IC, Chao NJ. Acute graft-vs-host disease: pathobiology and management. Exp Hematol. 2001;29(3):259–77.

Article  CAS  PubMed  Google Scholar 

Martino R, Romero P, Subirá M, Bellido M, Altés A, Sureda A, et al. Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation. Bone Marrow Transplant. 1999;24(3):283–7.

Article  CAS  PubMed  Google Scholar 

Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18(4):295–304. https://doi.org/10.1097/00007890-197410000-00001.

Article  CAS  PubMed  Google Scholar 

Farshidi F, Abedi G, Moosazadeh M, Afshari M. Seroprevalence of Cytomegalovirus Antibodies and Primary Infection among Women and Infants in Iran: A Meta-Analysis. Int J Cancer Manag. 2017;10(1):e3704. https://doi.org/10.17795/ijcp-3704.

Zuhair M, Smit GSA, Wallis G, Jabbar F, Smith C, Devleesschauwer B, et al. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev Med Virol. 2019;29(3):e2034.

Article  PubMed  Google Scholar 

Piukovics K, Terhes G, Gurbity-Pálfi T, Bereczki Á, Rárosi F, Deák J, et al. Cytomegalovirus infection in patients with haematological diseases and after autologous stem cell transplantation as consolidation: a single-centre study. Ann Hematol. 2017;96(1):125–31.

Article  CAS  PubMed  Google Scholar 

Cantoni N, Hirsch HH, Khanna N, Gerull S, Buser A, Bucher C, et al. Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease. Biol Blood Marrow Transplant. 2010;16(9):1309–14.

Article  PubMed  Google Scholar 

Francis SS, Wallace AD, Wendt GA, Li L, Liu F, Riley LW, et al. In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia. Blood. 2017;129(12):1680–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gallant R, Arroyo K, Bracci P, Metayer C, de Smith AJ, Wiemels JL. The effect of cytomegalovirus on pediatric acute lymphoblastic leukemia. Blood. 2021;138(Supplement 1):2281.

Article  Google Scholar 

Inagaki J, Noguchi M, Kurauchi K, Tanioka S, Fukano R, Okamura J. Effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia. Biol Blood Marrow Transplant. 2016;22(2):300–6.

Article  PubMed  Google Scholar 

Kantarjian H, Thomas D, O’Brien S, Cortes J, Giles F, Jeha S, et al. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer. 2004;101(12):2788–801.

Article  CAS  PubMed  Google Scholar 

Martin PJ, Rizzo JD, Wingard JR, Ballen K, Curtin PT, Cutler C, et al. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplantation. 2012;18(8):1150–63.

Article  Google Scholar 

IravaniSaadi M, Arandi N, Yaghobi R, Azarpira N, Geramizadeh B, Ramzi M. Aberrant expression of the miR-181b/miR-222 after hematopoietic stem cell transplantation in patients with acute myeloid leukemia. Indian J Hematol Blood Transfus. 2019;35(3):446–50.

Article  Google Scholar 

SAADI MI, Arandi N, Yaghobi R, Azarpira N, Geramizadeh B, Ramzi M. Up-regulation of the miR-92a and miR-181a in patients with acute myeloid leukemia and their inhibition with locked nucleic acid (LNA)-antimiRNA; introducing c-kit as a new target gene. Int J Hematol Oncol. 2018;32(4):238–47.

Saadi MI, Beigi MAB, Ghavipishe M, Tahamtan M, Geramizadeh B, Zare A, et al. The circulating level of interleukins 6 and 18 in ischemic and idiopathic dilated cardiomyopathy. J Cardiovasc Thorac Res. 2019;11(2):132.

Article  Google Scholar 

Miller S, Seet H, Khan Y, Wright C, Nadarajah R. Comparison of QIAGEN automated nucleic acid extraction methods for CMV quantitative PCR testing. Am J Clin Pathol. 2010;133(4):558–63.

Article  PubMed  Google Scholar 

Duyu M, Durmaz B, Gunduz C, Vergin C, Yilmaz Karapinar D, Aksoylar S, et al. Prospective evaluation of whole genome microRNA expression profiling in childhood acute lymphoblastic leukemia. Biomed Res Int. 2014;2014:967585.

Article  PubMed  PubMed Central  Google Scholar 

El-Khazragy N, Noshi MA, Abdel-Malak C, Zahran RF, Swellam M. miRNA-155 and miRNA-181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia. J Cell Biochem. 2019;120(4):6315–21.

Article  CAS  PubMed  Google Scholar 

Fayed D, Donia T, El-Shanshory M, Ali EMM, Mohamed TM. Evaluation of MicroRNA92, MicroRNA638 in acute lymphoblastic leukemia of Egyptian children. Asian Pac J Cancer Prev. 2021;22(5):1567–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie LN, Zhou F, Liu XM, Fang Y, Yu Z, Song NX, et al. Serum microRNA155 is increased in patients with acute graft-versus-host disease. Clin Transplant. 2014;28(3):314–23.

Article  CAS  PubMed  Google Scholar 

Wang F-Z, Weber F, Croce C, Liu C-G, Liao X, Pellett PE. Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication. J Virol. 2008;82(18):9065.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salaun B, Yamamoto T, Badran B, Tsunetsugu-Yokota Y, Roux A, Baitsch L, et al. Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets. J Transl Med. 2011;9(1):1–8.

Article  Google Scholar 

Kusenda B, Mraz M, Mayer J, Pospisilova S. MicroRNA biogenesis, functionality and cancer relevance. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006;150(2):205–15.

Article  CAS  PubMed  Google Scholar 

Frasca D, Diaz A, Romero M, Landin AM, Blomberg BB. Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine. Vaccine. 2015;33(12):1433–9.